Paper4698337
A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
Chiu J and 2 others. J Pediatr, 1973. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood. Papers, record 4698337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4698337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nephrotic Syndrome | Major topic |
| Prednisone | Major topic |
| Adolescent | |
| Alopecia | |
| Child | |
| Cyclophosphamide | |
| Cystitis | |
| Drug Synergism | |
| Female | |
| Humans | |
| Hypercholesterolemia | |
| Hypoproteinemia | |
| Leukopenia | |
| Male | |
| Prospective Studies | |
| Proteinuria | |
| Recurrence |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39576325 | Prolonged remission after cyclophosphamide or tacrolimus treatment in childhood nephrotic syndrome: a cohort study. | Pediatr Nephrol | 2025 | https://conductscience.org/library/papers/39576325 | PubMed |
| 39513526 | Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/39513526 | PubMed |
| 32297308 | Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32297308 | PubMed |
| 31145359 | Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/31145359 | PubMed |
| 25785660 | Corticosteroid therapy for nephrotic syndrome in children. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/25785660 | PubMed |
| 15378419 | Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise? | Pediatr Nephrol | 2005 | https://conductscience.org/library/papers/15378419 | PubMed |
| 12716220 | The management of idiopathic nephrotic syndrome in children. | Paediatr Drugs | 2003 | https://conductscience.org/library/papers/12716220 | PubMed |
| 4425844 | Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide. | Br Med J | 1974 | https://conductscience.org/library/papers/4425844 | PubMed |
| 3933709 | Long term effects of cyclophosphamide on testicular function. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/3933709 | PubMed |
| 3740921 | Minimal change nephrotic syndrome and cyclophosphamide. | Arch Dis Child | 1986 | https://conductscience.org/library/papers/3740921 | PubMed |
| 3688915 | Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie. | Arch Dis Child | 1987 | https://conductscience.org/library/papers/3688915 | PubMed |
| 2701868 | Immunosuppressive therapy in the nephrotic syndrome in children. | Pediatr Nephrol | 1989 | https://conductscience.org/library/papers/2701868 | PubMed |
| 2242303 | Testicular function following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study. | Pediatr Nephrol | 1990 | https://conductscience.org/library/papers/2242303 | PubMed |
| 2040345 | The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies. | Eur J Pediatr | 1991 | https://conductscience.org/library/papers/2040345 | PubMed |
| 1718684 | Management of nephrotic syndrome in childhood. | Drugs | 1991 | https://conductscience.org/library/papers/1718684 | PubMed |
| 1616833 | Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome. | Pediatr Nephrol | 1992 | https://conductscience.org/library/papers/1616833 | PubMed |
| 1278059 | Clinical use of immunosuppressive drugs: part II. | Drugs | 1976 | https://conductscience.org/library/papers/1278059 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4698337
GET https://conductscience.org/api/papers/v1/4698337/authors